SCHEMBL7812669

SCHEMBL7812669

Cc1cc(F)ccc1Nc1nc(N2CCc3ccccc3C2C)c2cccc(OCCO)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7810482 0.92 MEN1 (0.35)
Hydrochloric Acid SCHEMBL7825442 0.91 MEN1 (0.35)
SCHEMBL7818262 0.89 AXL (0.34)
SCHEMBL7810109 0.89
SCHEMBL7810103 0.89
SCHEMBL7811240 0.89
Hydrochloric Acid SCHEMBL7820251 0.89 AXL (0.34)
Hydrochloric Acid SCHEMBL7809762 0.88
Hydrochloric Acid SCHEMBL7809766 0.88
Hydrochloric Acid SCHEMBL7825393 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0677049-B1 QUINAZOLINE DERIVATIVES YUHAN CORP LTD (KR) 2001-07-25 EP claimed
EP-0677049-B1 QUINAZOLINE DERIVATIVES YUHAN CORP LTD (KR) 2001-07-25 EP disclosed
US-5686458-A Quinazoline deriviates for treating peptic ulcer YUHAN CORPORATION (KR) 1997-11-11 US disclosed
EP-0677049-A1 QUINAZOLINE DERIVATIVES YUHAN CORPORATION, LTD. (KR) 1995-10-18 EP disclosed
WO-1994014795-A1 QUINAZOLINE DERIVATIVES YUHAN CORPORATION (KR) 1994-07-07 WO disclosed